145 related articles for article (PubMed ID: 33450126)
1. Targeted caspofungin prophylaxis for invasive aspergillosis in high-risk liver transplant recipients, a single-center experience.
Chakravarti A; Butler-Laporte G; Carrier FM; Bilodeau M; Huard G; Corsilli D; Savard P; Luong ML
Transpl Infect Dis; 2021 Aug; 23(4):e13568. PubMed ID: 33450126
[TBL] [Abstract][Full Text] [Related]
2. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.
Fortún J; Muriel A; Martín-Dávila P; Montejo M; Len O; Torre-Cisneros J; Carratalá J; Muñoz P; Fariñas C; Moreno A; Fresco G; Goikoetxea J; Gavaldá J; Pozo JC; Bodro M; Vena A; Casafont F; Cervera C; Silva JT; Aguado JM;
Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of the risk factors for developing aspergillosis following cardiac transplant.
Cook JC; Cook A; Tran RH; Chang PP; Rodgers JE
Clin Transplant; 2018 Sep; 32(9):e13367. PubMed ID: 30074643
[TBL] [Abstract][Full Text] [Related]
5. A risk profile for invasive aspergillosis in liver transplant recipients.
Rosenhagen M; Feldhues R; Schmidt J; Hoppe-Tichy T; Geiss HK
Infection; 2009 Aug; 37(4):313-9. PubMed ID: 19629387
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
7. Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.
Aguilar CA; Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Ussetti P; Chin-Hong PV; Sole A; Holmes-Liew C; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Singer LG; Husain S
J Heart Lung Transplant; 2018 Oct; 37(10):1226-1234. PubMed ID: 30139546
[TBL] [Abstract][Full Text] [Related]
8. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.
Minari A; Husni R; Avery RK; Longworth DL; DeCamp M; Bertin M; Schilz R; Smedira N; Haug MT; Mehta A; Gordon SM
Transpl Infect Dis; 2002 Dec; 4(4):195-200. PubMed ID: 12535262
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
[TBL] [Abstract][Full Text] [Related]
10. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients.
Balogh J; Gordon Burroughs S; Boktour M; Patel S; Saharia A; Ochoa RA; McFadden R; Victor DW; Ankoma-Sey V; Galati J; Monsour HP; Fainstein V; Li XC; Grimes KA; Gaber AO; Aloia T; Ghobrial RM
Liver Transpl; 2016 Feb; 22(2):163-70. PubMed ID: 26515643
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
13. Weekly high-dose liposomal amphotericin B prevents invasive aspergillosis after heart transplantation.
Cointault O; Joly M; Cassaing S; Labaste F; Danet C; Porte L; Guitard J; Kamar N; Faguer S;
Transpl Infect Dis; 2021 Dec; 23(6):e13745. PubMed ID: 34657372
[TBL] [Abstract][Full Text] [Related]
14. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
15. Invasive aspergillosis in liver transplant recipients.
Melenotte C; Aimanianda V; Slavin M; Aguado JM; Armstrong-James D; Chen YC; Husain S; Van Delden C; Saliba F; Lefort A; Botterel F; Lortholary O
Transpl Infect Dis; 2023 Jun; 25(3):e14049. PubMed ID: 36929539
[TBL] [Abstract][Full Text] [Related]
16. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
Mohammad RA; Klein KC
Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
[TBL] [Abstract][Full Text] [Related]
17. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
He SY; Makhzoumi ZH; Singer JP; Chin-Hong PV; Arron ST
Transpl Infect Dis; 2015 Feb; 17(1):14-20. PubMed ID: 25620387
[TBL] [Abstract][Full Text] [Related]
18. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of aspergillosis in orthotopic liver transplant recipients].
Liu ZW; Zou WL; Zhu XD; Zhang XL; Liu Y; Shen ZY
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):171-4. PubMed ID: 15760547
[TBL] [Abstract][Full Text] [Related]
20. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]